CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 53,100 shares, a growth of 14.7% from the April 30th total of 46,300 shares. Currently, 0.8% of the shares of the company are […]